Alison Moore, Chief Technical Officer at Allogene Therapeutics, Inc. (ALLO), sold 96,033 shares at $26.74 ($2.6M) on 2019-06-03, disclosed to the SEC on 2019-06-05.
Open-market sale of $2.6M ALLO by Chief Technical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.74 | 47,205 | $1.3M | 49.1% |
| 2 | $26.74 | 47,205 | $1.3M | 49.1% |
| 3 | $27.31 | 1,623 | $44K | 1.7% |
| Total | $26.75 avg | 96,033 | $2.6M | 100% |
| Filing → |
| CDXS | SELL | 2025-10-15 | $16K | — | Filing → |
| ALLO | SELL | 2022-03-17 | $133K | — | Filing → |
| ALLO | SELL | 2021-03-17 | $470K | — | Filing → |